Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention control.

Saved in:
Bibliographic Details
Title: Immune activation during broadly neutralizing antibody-mediated HIV suppression prior to post-intervention control.
Authors: Wagner JA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Sandel DA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Patel RK; UCSF CoLabs Initiative, University of California, San Francisco, San Francisco, CA, USA., Gruenhagen GW; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Tibúrcio R; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Singh SS; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Schwartz K; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Traglia M; The Gladstone Institutes, San Francisco, CA, USA., Milani P; Vitalant Research Institute, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA., Di Germanio C; Vitalant Research Institute, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA., Ilan S; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Dalhuisen T; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Hoh R; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Williams MC; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Shimoda M; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Thomas R; The Gladstone Institutes, San Francisco, CA, USA., Juelg B; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Spitzer MH; Department of Otolaryngology - Head and Neck Surgery, University of California, San Francisco, San Francisco, CA, USA.; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, USA., Deitchman AN; Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, CA, USA., Busch MP; Vitalant Research Institute, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA., Fragiadakis GK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; UCSF CoLabs Initiative, University of California, San Francisco, San Francisco, CA, USA., Hunt PW; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Peluso MJ; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Deeks SG; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Rutishauser RL; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2026 Jun 02. Date of Electronic Publication: 2026 Jun 02.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.64898/2026.05.29.728863